Eric Cheung
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Fibroblast Growth Factor Research 4
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Howard A. Liebman (2 shared papers)Ranjana H. Advani (3 shared papers)Stephen M. Ansell (3 shared papers)Ahmed Sawas (3 shared papers)Ann S. LaCasce (3 shared papers)David S. Edwards (2 shared papers)Julie M. Vose (3 shared papers)Milind Rajopadhye (2 shared papers)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (3 papers)Bioconjugate Chemistry (2 papers)Hematology/Oncology Clinics of North America (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Eric Cheung
20 papers receiving 491 citations
Peers
Comparison fields: 5 of 59
- Pathology and Forensic Medicine 228
- Oncology 244
- Neurology 119
- Genetics 58
- Immunology and Allergy 30
Countries citing papers authored by Eric Cheung
This map shows the geographic impact of Eric Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Cheung more than expected).
Fields of papers citing papers by Eric Cheung
This network shows the impact of papers produced by Eric Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Cheung. The network helps show where Eric Cheung may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Cheung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 152 | |
| 2 | 2019 | 56 | |
| 3 | 2001 | 48 | |
| 4 | 2015 | 43 | |
| 5 | 2006 | 38 | |
| 6 | 2009 | 29 | |
| 7 | 2009 | 23 | |
| 8 | 2000 | 22 | |
| 9 | 2014 | 20 | |
| 10 | 2007 | 16 | |
| 11 | 2005 | 11 | |
| 12 | Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. | 2008 | 8 |
| 13 | 2019 | 8 | |
| 14 | 2007 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 1995 | 4 | |
| 17 | 2008 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2018 | 3 | |
| 20 | 1995 | 2 |
About Eric Cheung
Eric Cheung is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 21 papers that have together received 498 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Fibroblast Growth Factor Research (4 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (228 citations), Oncology (244 citations), Neurology (119 citations), Genetics (58 citations) and Immunology and Allergy (30 citations). Eric Cheung has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Howard A. Liebman, Ranjana H. Advani, Stephen M. Ansell, Ahmed Sawas, Ann S. LaCasce, David S. Edwards, Julie M. Vose, Milind Rajopadhye, Neil C. Josephson and Miguel Islas‐Ohlmayer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bioconjugate Chemistry, Hematology/Oncology Clinics of North America and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.